ABSTRACT A series of 2-(substituted phenyl)-3-[5'-(2''-oxo-2H-chromen-3'-yl)-1,3,4-oxadiazol-2-yl]-1,3-thiazolidin-4-ones 4-16 were synthesized in good yield and evaluated for their possible anticonvulsant and neurotoxic study. All the synthesized compounds were in good agreement with elemental and spectral data. Majority of the compounds were active in MES test. All the compounds were less neurotoxic than the standard drug phenytoin.
INTRODUCTION
Many compounds bearing five-membered heterocyclic rings such as triazoles, oxadiazoles, thiadiazoles have been synthesized and evaluated for their anticonvulsant activities. [1] [2] [3] In our previous work, we reported that benzothiazole, sulphonamide and coumarin derivatives had considerable anticonvulsant activity. [4] [5] [6] [7] The present work was focused on the synthesis and anticonvulsant screening of new 2-(substituted phenyl)-3-[5'-(2''-oxo-2H-chromen-3'-yl)-1,3,4-oxadiazol-2-yl]-1,3-thiazolidin-4-ones. According to the proposed pharmacophoric requirements for anticonvulsant action (i) aryl binding site with a hydrophobic group; (ii) hydrogen bonding domain exemplified by the presence of the (-NHCO-) grouping; (iii) two electron donor system; (iv) distal hydrophobic binding site whose size determines the type of activity, 8 we have designed and synthesized the titled compounds 4-16. The lipophilic aryl ring was replaced with coumarin ring, a versatile heterocyclic molecule; hydrogen accepter domain was represented by thiazolidinone moiety (Fig. 1 ). Interestingly these compounds have shown appreciable anticonvulsant activity. The three dimensional optimized structure of the titled compounds is depicted in (Fig. 2) .
Review Article EXPERIMENTAL Chemistry
Melting points were determined in open capillary tubes and are uncorrected. Elemental data of C, H and N were within ± 0.4% of the theoretical values. 1 H NMR spectra were recorded on a Bruker model DRX 300 NMR spectrometer in DMSO-d 6 using tetramethylsilane (TMS) as an internal standard. IR spectra were recorded on BIO-RAD FTS 135 spectrometer using KBr pellet. 2-Oxo-2H-chromene-3-carbohydrazide (1): The starting compound 2-oxo-2H-chromene-3-carbohydrazide was prepared as described previously. 
Anticonvulsant activity
The anticonvulsant activity of the synthesized compounds was determined by evaluation of the ability of the compounds to protect mice convulsions induced by electroshock and neurotoxicity by rotorod method as routine model. [10] [11] Male albino mice (Swiss, 18-25 g) were used as experimental animals. The test compounds were suspended in polyethylene glycol (PEG). Analytical and spectral data of all the synthesized compounds were in good agreement with the composition of synthesized compounds. The data of physicochemical properties of all the compounds are given in (Table 1) .
Siddiqui N et al. Table 1 . Physical data of compounds (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) a Elemental analysis for C, H, N and S were within 0.4% and 0.3% respectively of the theoretical values. b Eluents used in TLC were Toluene: Ethyl acetate: Formic acid (5:4:1) for compounds. c R M = log (1-1/R f ).
NT-Neurotoxicity:
The rotorod test was used to evaluate neurotoxicity. The animal was placed on a 3.2 cm diameter knurled rod rotating at 6 rpm. Normal mice can remain on a rod rotating at this speed indefinitely. Neurological toxicity is defined as the failure of the animal to remain on the rod for 1 min.
RESULTS AND DISCUSSION
The synthesized titled compounds 4-16 were initially screened at 30, 100 and 300 mg/kg intraperitoneally in mice for anticonvulsant activity. All the compounds were active in MES test at a dose of 300 mg/kg indicative of their ability to protect the seizure spread. At a dose of 30 mg/kg, the compounds that showed protection in half or more tested mice were 8, 12, 13, 14 and 15 after 0.5 h. These compounds also showed protection against MES test after 4 h but at higher dose of 100 mg/kg. At a dose of 100 mg/kg, the compounds that
Lipophilicity determination
The dependence of biological activity of congeneric agents on lipophilic character has been shown in many types of drug action. The anticonvulsant activity of different types of compounds was reported to be correlated with lipophilicity 12 . The experimental log P values were determined using octanol-water method 13 for compounds, which showed significant protection. The compound 12 and 13 had log P value of 1.0 and 1.65 respectively, which were near to optimum log P value of ± 2. Among the compounds showing anticonvulsant activity, compounds with more lipophilic substitutions like OCH 3 , NO 2 and Cl group in distal aryl ring are more active. Basic structure of the compounds fulfilled all the pharmacophoric structural requirements.
CONCLUSION
In conclusion, results confirmed the pharmacophoric model elements are necessary for anticonvulsant activity. Substitutions with OCH 3 , Cl and NO 2 group at distal aryl ring showed significant MES activity as compared to other substituents with bigger hydrophobic domain. 
MES-Maximal electroshock seizure Test
Maximal electroshock seizures were elicited with a 60 cycle altering current of 50 mA intensity (5-7 times that necessary to elicit minimal electroshock seizures) delivered for 0.25 s via corneal electrodes. A drop of 0.9% saline was instilled in the eye prior to application of the electrodes in order to prevent the death of the animal. Abolition of the hind limb tonic extensor component of the seizure is defined as protection, and results are expressed as number of animal protected/ number of animals tested. Initial anticonvulsant activity and neurotoxicity data for titled compounds are reported in (Table 2) . Table 2 . Anticonvulsant and neurotoxicity results of the titled compounds (4-16) a Doses of 30, 100 and 300 mg/kg were administered. The figure in the table indicates the minimum dose whereby bioactivity was demonstrated in half or more of the animals. The animals were examined 0.5 and 4 h after administration. The (-) indicates an absence of activity at maximum dose administered (300 mg/kg).
b Data from references. [14] [15] [16] showed protection were 4, 7, 9 and 11 after 0.5 h. These compounds also showed protection against MES test after 4 h but at a higher dose of 300 mg/kg. Compounds, which showed protection against MES test at 300 mg/ kg after 0.5 h and 4 h, were 5, 10 and 16.
In neurotoxicity screening, the compounds 4, 5, 6 and 8 were devoid of toxicity after 4 h interval. All the compounds showed neurotoxicity at a higher dose of 300 mg/kg after 0.5 h time interval. The compounds 12 and 13, showed neurotoxicity at a dose of 100 mg/ kg after 4 h. The compounds, which contained substituents, like NO 2 , Cl and OCH 3 at distal phenyl ring showed potent activity against MES test. The compounds with substituents like OH and F at distal phenyl ring showed moderate activity against MES test. The compounds with substituents like N(CH 3 ) 2 , 3,4-(OCH 3 ) 2 and H showed protection against MES test but at higher dose of 300 mg/kg. The thiazolidinone moiety, which contains S-CH 2 , increases the lipophilicity of the compounds.
